The potential of biosimilar rituximab: reducing budgets and increasing access to treatment
Myeloma 2016: Panel discussion on novel treatments
Keith Stewart et al.
Promising uses for PET/CT and MRI in clinical practice
How effective are current drug treatments for patients with myeloma kidney disease?
Studying the evolution of acute myeloid leukemia (AML) relapse